Cargando…

Implementing national COVID-19 vaccination programmes in sub-Saharan Africa- early lessons from Zimbabwe: a descriptive cross-sectional study

INTRODUCTION: Zimbabwe was one of the first countries to run a national COVID-19 vaccination programme in Africa. Lessons learnt could inform the roll-out of similar programmes in sub-Saharan Africa. To describe the trends of uptake of the COVID-19 vaccines in the first three months (February - May...

Descripción completa

Detalles Bibliográficos
Autores principales: Murewanhema, Grant, Burukai, Trouble Victor, Chireka, Brighton, Kunonga, Edward
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The African Field Epidemiology Network 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8720230/
https://www.ncbi.nlm.nih.gov/pubmed/35018213
http://dx.doi.org/10.11604/pamj.2021.40.180.30824
_version_ 1784625099136040960
author Murewanhema, Grant
Burukai, Trouble Victor
Chireka, Brighton
Kunonga, Edward
author_facet Murewanhema, Grant
Burukai, Trouble Victor
Chireka, Brighton
Kunonga, Edward
author_sort Murewanhema, Grant
collection PubMed
description INTRODUCTION: Zimbabwe was one of the first countries to run a national COVID-19 vaccination programme in Africa. Lessons learnt could inform the roll-out of similar programmes in sub-Saharan Africa. To describe the trends of uptake of the COVID-19 vaccines in the first three months (February - May 2021) of the Zimbabwe vaccination programme and the lessons learnt. METHODS: a secondary descriptive analysis of routinely available COVID-19 vaccination data extracted from the daily situation reports published by the Ministry of Health and Child Care. RESULTS: in the first three months of the programme, 1 020 078 doses were administered, with 675 678 being first doses and 344 400 were second doses. Using population estimates, at three months, 5.2% of the population had received at least one dose and 2.6% had received the full two doses. Uptake was initially slow, followed by a gradual, and subsequently an exponential increase. CONCLUSION: by the end of May 2021, Zimbabwe had rolled out one of the largest COVID-19 vaccination programme in sub-Saharan Africa. The uptake followed a pattern and trend that is consistent with vaccine hesitancy reported in the literature, driven by a combination of confidence, complacency and convenience factors. The gradual increase in uptake followed a series of national and local community engagement programmes. The roll-out of similar programmes must recognise likely patterns of uptake across the population and ensure plans are in place to address vaccine hesitancy. The available data did not allow granular analysis to understand the demographics of people who participated in the programme, which is important for surveillance, targeted action, preventing inequalities and ensuring adequate and proportionate protection of residents prioritising the most vulnerable. Further analysis of the process, outcomes and impact of the programme will be helpful in informing the roll-out of similar programmes across Africa.
format Online
Article
Text
id pubmed-8720230
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher The African Field Epidemiology Network
record_format MEDLINE/PubMed
spelling pubmed-87202302022-01-10 Implementing national COVID-19 vaccination programmes in sub-Saharan Africa- early lessons from Zimbabwe: a descriptive cross-sectional study Murewanhema, Grant Burukai, Trouble Victor Chireka, Brighton Kunonga, Edward Pan Afr Med J Research INTRODUCTION: Zimbabwe was one of the first countries to run a national COVID-19 vaccination programme in Africa. Lessons learnt could inform the roll-out of similar programmes in sub-Saharan Africa. To describe the trends of uptake of the COVID-19 vaccines in the first three months (February - May 2021) of the Zimbabwe vaccination programme and the lessons learnt. METHODS: a secondary descriptive analysis of routinely available COVID-19 vaccination data extracted from the daily situation reports published by the Ministry of Health and Child Care. RESULTS: in the first three months of the programme, 1 020 078 doses were administered, with 675 678 being first doses and 344 400 were second doses. Using population estimates, at three months, 5.2% of the population had received at least one dose and 2.6% had received the full two doses. Uptake was initially slow, followed by a gradual, and subsequently an exponential increase. CONCLUSION: by the end of May 2021, Zimbabwe had rolled out one of the largest COVID-19 vaccination programme in sub-Saharan Africa. The uptake followed a pattern and trend that is consistent with vaccine hesitancy reported in the literature, driven by a combination of confidence, complacency and convenience factors. The gradual increase in uptake followed a series of national and local community engagement programmes. The roll-out of similar programmes must recognise likely patterns of uptake across the population and ensure plans are in place to address vaccine hesitancy. The available data did not allow granular analysis to understand the demographics of people who participated in the programme, which is important for surveillance, targeted action, preventing inequalities and ensuring adequate and proportionate protection of residents prioritising the most vulnerable. Further analysis of the process, outcomes and impact of the programme will be helpful in informing the roll-out of similar programmes across Africa. The African Field Epidemiology Network 2021-11-24 /pmc/articles/PMC8720230/ /pubmed/35018213 http://dx.doi.org/10.11604/pamj.2021.40.180.30824 Text en Copyright: Grant Murewanhema et al. https://creativecommons.org/licenses/by/4.0/The Pan African Medical Journal (ISSN: 1937-8688). This is an Open Access article distributed under the terms of the Creative Commons Attribution International 4.0 License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Murewanhema, Grant
Burukai, Trouble Victor
Chireka, Brighton
Kunonga, Edward
Implementing national COVID-19 vaccination programmes in sub-Saharan Africa- early lessons from Zimbabwe: a descriptive cross-sectional study
title Implementing national COVID-19 vaccination programmes in sub-Saharan Africa- early lessons from Zimbabwe: a descriptive cross-sectional study
title_full Implementing national COVID-19 vaccination programmes in sub-Saharan Africa- early lessons from Zimbabwe: a descriptive cross-sectional study
title_fullStr Implementing national COVID-19 vaccination programmes in sub-Saharan Africa- early lessons from Zimbabwe: a descriptive cross-sectional study
title_full_unstemmed Implementing national COVID-19 vaccination programmes in sub-Saharan Africa- early lessons from Zimbabwe: a descriptive cross-sectional study
title_short Implementing national COVID-19 vaccination programmes in sub-Saharan Africa- early lessons from Zimbabwe: a descriptive cross-sectional study
title_sort implementing national covid-19 vaccination programmes in sub-saharan africa- early lessons from zimbabwe: a descriptive cross-sectional study
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8720230/
https://www.ncbi.nlm.nih.gov/pubmed/35018213
http://dx.doi.org/10.11604/pamj.2021.40.180.30824
work_keys_str_mv AT murewanhemagrant implementingnationalcovid19vaccinationprogrammesinsubsaharanafricaearlylessonsfromzimbabweadescriptivecrosssectionalstudy
AT burukaitroublevictor implementingnationalcovid19vaccinationprogrammesinsubsaharanafricaearlylessonsfromzimbabweadescriptivecrosssectionalstudy
AT chirekabrighton implementingnationalcovid19vaccinationprogrammesinsubsaharanafricaearlylessonsfromzimbabweadescriptivecrosssectionalstudy
AT kunongaedward implementingnationalcovid19vaccinationprogrammesinsubsaharanafricaearlylessonsfromzimbabweadescriptivecrosssectionalstudy